It was proposed that in the healthy eye, pro-inflammatory mFasL is normally cleaved to sFasL, the anti-inflammatory and neuroprotective form; however, in glaucoma, the balance of mFasL and sFasL shifts to favor the neurodestructive mFasL as the dominant form of FasL. The gene discussed is FASLG; the disease is glaucoma.